Recovering from depression with repetitive transcranial magnetic stimulation (rTMS): a systematic review and meta-analysis of preclinical studies.
Recovering from depression with repetitive transcranial magnetic stimulation (rTMS): a systematic review and meta-analysis of preclinical studies.
复制标题
通过重复的经颅磁刺激(RTMS)从抑郁症中恢复:临床前研究的系统综述和荟萃分析。
DOI:
10.1038/s41398-020-01055-2
复制
发表时间:
2020-11-10
影响因子:
6.8
通讯作者:
Zoratto F
中科院分区:
文献类型:
--
作者:
De Risio L;Borgi M;Pettorruso M;Miuli A;Ottomana AM;Sociali A;Martinotti G;Nicolò G;Macrì S;di Giannantonio M;Zoratto F
Repetitive transcranial magnetic stimulation (rTMS) has gained growing interest for the treatment of major depression (MDD) and treatment-resistant depression (TRD). Most knowledge on rTMS comes from human studies as preclinical application has been problematic. However, recent optimization of rTMS in animal models has laid the foundations for improved translational studies. Preclinical studies have the potential to help identify optimal stimulation protocols and shed light on new neurobiological-based rationales for rTMS use. To assess existing evidence regarding rTMS effects on depressive-like symptoms in rodent models, we conducted a comprehensive literature search in accordance with PRISMA guidelines (PROSPERO registration number: CRD42019157549). In addition, we conducted a meta-analysis to determine rTMS efficacy, performing subgroup analyses to examine the impact of different experimental models and neuromodulation parameters. Assessment of the depressive-like phenotype was quite homogeneous whilst rTMS parameters among the 23 included studies varied considerably. Most studies used a stress-induced model. Overall, results show a largely beneficial effect of active rTMS compared to sham stimulation, as reflected in the statistically significant recovery of both helplessness (SDM 1.34 [1.02;1.66]) and anhedonic (SDM 1.87 [1.02;2.72]) profiles. Improvement of the depressive-like phenotype was obtained in all included models and independently of rTMS frequency. Nonetheless, these results have limited predictive value for TRD patients as only antidepressant-sensitive models were used. Extending rTMS studies to other MDD models, corresponding to distinct endophenotypes, and to TRD models is therefore crucial to test rTMS efficacy and to develop cost-effective protocols, with the potential of yielding faster clinical responses in MDD and TRD.
登录
查看更多内容
影响因子:
2.9
作者:
Duprat R;De Raedt R;Wu GR;Baeken C
通讯作者:
Baeken C
影响因子:
82.9
作者:
Drysdale AT;Grosenick L;Downar J;Dunlop K;Mansouri F;Meng Y;Fetcho RN;Zebley B;Oathes DJ;Etkin A;Schatzberg AF;Sudheimer K;Keller J;Mayberg HS;Gunning FM;Alexopoulos GS;Fox MD;Pascual-Leone A;Voss HU;Casey BJ;Dubin MJ;Liston C
通讯作者:
Liston C
影响因子:
10.6
作者:
Carola, Valeria;Frazzetto, Giovanni;Gross, Cornelius
通讯作者:
Gross, Cornelius
影响因子:
5.3
作者:
Gersner, Roman;Kravetz, Elena;Zangen, Abraham
通讯作者:
Zangen, Abraham
DOI:
10.1016/s0140-6736(17)32802-7
发表时间:
2018-04-07
期刊:
Lancet (London, England)
影响因子:
--
作者:
Cipriani A;Furukawa TA;Salanti G;Chaimani A;Atkinson LZ;Ogawa Y;Leucht S;Ruhe HG;Turner EH;Higgins JPT;Egger M;Takeshima N;Hayasaka Y;Imai H;Shinohara K;Tajika A;Ioannidis JPA;Geddes JR
通讯作者:
Geddes JR